C3aR and C5aR Modulate T-cell Responses in the MRL Mouse
C3aR and C5aR Modulate T-cell Responses in the MRL Mouse
批准号:
8397223
负责人:
MICHAEL C BRAUN
金额:
$1.48万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2012-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Systemic Lupus Erythematosus (SLE) is a heterogeneous disorder characterized by autoimmunity and the
development of progressive immune complex renal disease. The pathogenesis of SLE is complex and multi-
factorial; substantial clinical and experimental data supports roles for auto-antibodies, immune complexes,
apoptosis, and effector T-cells in the development of SLE. Disturbances in the complement system are
strongly associated with the development and progression of many forms of SLE particularily lupus nephrits.
Complement activation results in the production of anaphylatoxins, C3a and C5a, which signal through
ubiquitiously expressed G-protein coupled receptors (C3aR and C5aR). Signaling via the C3aR and C5aR
have historically thought to function to active innate immune responses. The studies contained in this
proposal are desinged to define and characterize the ability of C3aR and C5aR to alter adaptive immune
responses in a biologically relevant complement depedent model of human disease, namely the MRL/lpr
mouse model of lupus nephritis. Mice with targeted deletions of C3aR and C5aR as well as mice deficient in
both the C3aR and the C5aR have been back-crossed 9 generations on to the MRL/lpr genetic background.
Comparative studies of renal injury and immunologic responses including antigent presenting cell function,
T-cell, and B-cell function will be performed. Additionally, experiments investigating renal parenchymal
reponses in terms of cellualr proliferation, extra-cellular matrix production, and apoptosis will be performed.
These studies are designed to advance our understanding of the mechanisms by which complement
activation products modulate cellular immune responses and renal parenchymal responses in immune
mediated renal injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of C7 in Resistance to Neisseria Infections
-
批准号:7962860
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2010
-
负责人:MICHAEL C BRAUN
-
依托单位:
Role of C7 in Resistance to Neisseria Infections
-
批准号:8134950
-
项目类别:
-
资助金额:$24.41万
-
财政年份:2010
-
负责人:MICHAEL C BRAUN
-
依托单位:
C3aR and C5aR Modulate T-cell Responses in the MRL Mouse
-
批准号:7903765
-
项目类别:
-
资助金额:$9.9万
-
财政年份:2009
-
负责人:MICHAEL C BRAUN
-
依托单位:
C3aR and C5aR Modulate T-cell Responses in the MRL Mouse
-
批准号:7031858
-
项目类别:
-
资助金额:$28.85万
-
财政年份:2006
-
负责人:MICHAEL C BRAUN
-
依托单位:
C3aR and C5aR Modulate T-cell Responses in the MRL Mouse
-
批准号:7368084
-
项目类别:
-
资助金额:$28.97万
-
财政年份:2006
-
负责人:MICHAEL C BRAUN
-
依托单位:
C3aR and C5aR Modulate T-cell Responses in the MRL Mouse
-
批准号:7570091
-
项目类别:
-
资助金额:$28.97万
-
财政年份:2006
-
负责人:MICHAEL C BRAUN
-
依托单位:
C3aR and C5aR Modulate T-cell Responses in the MRL Mouse
-
批准号:7212120
-
项目类别:
-
资助金额:$29.56万
-
财政年份:2006
-
负责人:MICHAEL C BRAUN
-
依托单位:
Urinary Biomarkers in Murine MPGN
-
批准号:7140339
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2005
-
负责人:MICHAEL C BRAUN
-
依托单位:
Urinary Biomarkers in Murine MPGN
-
批准号:6962745
-
项目类别:
-
资助金额:$14.85万
-
财政年份:2005
-
负责人:MICHAEL C BRAUN
-
依托单位:
The Role of C3a and C5a in BEA Induced Nephritis
-
批准号:6532064
-
项目类别:
-
资助金额:$12.54万
-
财政年份:2002
-
负责人:MICHAEL C BRAUN
-
依托单位:
The Role of C3a and C5a in BEA Induced Nephritis
-
批准号:6648320
-
项目类别:
-
资助金额:$12.54万
-
财政年份:2002
-
负责人:MICHAEL C BRAUN
-
依托单位:
The Role of C3a and C5a in BEA Induced Nephritis
-
批准号:6932975
-
项目类别:
-
资助金额:$12.54万
-
财政年份:2002
-
负责人:MICHAEL C BRAUN
-
依托单位:
The Role of C3a and C5a in BEA Induced Nephritis
-
批准号:7102777
-
项目类别:
-
资助金额:$12.64万
-
财政年份:2002
-
负责人:MICHAEL C BRAUN
-
依托单位:
The Role of C3a and C5a in BEA Induced Nephritis
-
批准号:6782688
-
项目类别:
-
资助金额:$12.54万
-
财政年份:2002
-
负责人:MICHAEL C BRAUN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
C5a/C5aR通路抑制P21表达在胃癌发生中的机制研究
-
批准号:CSTB2023NSCQ-MSX0699
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:陈军
-
依托单位:
C5aR通过调控Batf2核转位促进巨噬细胞M1极化加重肾脏缺血再灌注损伤的作用及机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:戚若晨
-
依托单位:
C5a/C5aR通过TLR-4/TRAF6/NF-kb通路介导糖尿病视网膜病变炎症损伤的机制研究
-
批准号:82000768
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王君
-
依托单位:
补体C5a/C5aR通路在EV71感染致血脑屏障损伤中的作用
-
批准号:82002147
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:晋乐飞
-
依托单位:
C5aR共刺激信号促进CAR-T分化为Th17亚型增强抗白血病的作用和机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:赖沛龙
-
依托单位:
金黄色葡萄球菌PV杀白细胞素S组分靶向C5aR下调HDAC6在抑制肝癌细胞上皮间质转化中的作用和机制研究
-
批准号:81972001
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:马筱玲
-
依托单位:
补体C5a/C5aR信号调控CD45+红系前体细胞免疫抑制功能及其机制研究
-
批准号:31900627
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:查皓然
-
依托单位:
以C5aR为新型胞内共刺激分子增强CAR-T抗白血病的基础与临床研究
-
批准号:81870121
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2018
-
负责人:赖沛龙
-
依托单位:
补体C5a/C5aR通路促pDCs分化和功能形成介导银屑病的机制研究
-
批准号:81873881
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:许桂莲
-
依托单位:
阿加曲班改性滤器膜通过凝血酶介导的补体C5a/C5aR通路影响微炎症形成的机制研究
-
批准号:81800680
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:府晓
-
依托单位: